Is acquired idiopathic sideroblastic anemia (AISA) a disorder of mitochondrial DNA?

Leukemia

Volumn 7, Issue 12, 1993, Pages 2069-2076

  Gattermann, Norbert ^a   Aul, Carlo ^a   Schneider, Wolfgang ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC FERROCYANIDE; IRON; MITOCHONDRIAL DNA;

AGING; BONE MARROW; CYTOLOGY; DNA SEQUENCE; ELECTRON MICROSCOPY; ERYTHROBLAST; HEME SYNTHESIS; HUMAN; IRON METABOLISM; MITOCHONDRION; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY CHAIN; SIDEROBLASTIC ANEMIA;

AGING; ANEMIA, SIDEROBLASTIC; DNA, MITOCHONDRIAL; HEME; HUMAN; IRON; MITOCHONDRIA; MUTATION; OXIDATION-REDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0027753864     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Björkman SE. Chronic refractory anemia with sideroblastic bone marrow. A study of four cases. Blood 1956;11:250-259.
2. Kushner JP, Lee GR, Wintrobe MM, Cartwright GE. Idiopathic refractory sideroblastic anemia. Clinical and laboratory investigation of 17 patients and review of the literature. Medicine 1971;50:139-159.
3. Pasanen AVO, Vuopio P, Borgström GH, Tenhunen R. Haem biosynthesis in refractory sideroblastic anaemia associated with the preleukemic syndrome. Scand J Haematol 1981;27:35-44.
4. Vogler WR, Mingioli ES. Porphyrin synthesis and heme synthetase activity in pyridoxine-responsive anemia. Blood 1968;32:979.
5. Romslo I, Brun A, Sandberg S, Bottomley S, Hovding G, Talstad I. Sideroblastic anemia with markedly increased free erythrocyte protoporphyrin without dermal photosensitivity. Blood 1982;59:628-633.
6. Stavem P, Romslo I, Hovig T, Rootwelt K, Emblem R. Ferrochelatase deficiency in the bone marrow in a syndrome of congenital hypochromic microcytic anaemia, hyperferraemia and iron overload of the liver. Scand J Gastroenterol 1985;20(Suppl 107):73-81.
7. Bottomley SS, Müller-Eberhard U. Pathophysiology of heme synthesis. Semin Hematol 1988;25:282-302.
8. Morrow JJ, Urata G, Goldberg A. The effect of lead and ferrous and ferric iron on δ-aminolaevulinic acid synthetase. Clin Sci 1969;37:533-538.
9. May A, de Souza P, Barnes K, Kaaba S, Jacobs A. Erythroblast iron metabolism in sideroblastic marrows. Br J Haematol 1982;52:611-621.
10. Fitzsimons EJ, May A, Elder GH, Jacobs A. 5-Aminolaevulinic acid synthase activity in developing human erythroblasts. Br J Haematol 1988;69:281-285.
11. Bottomley SS, Healy HM, Brandenburg MA, May BK. 5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells. Am J Hematol 1992;41:76-83.
12. Jacobs A. Primary acquired sideroblastic anaemia. Br J Haematol 1986;64:415-418.
13. Harbin BM, Dailey HA. Orientation of ferrochelatase in bovine liver mitochondria. Biochemistry 1985;24:366-370.
14. Bessis MC, Jansen WN. Sideroblastic anemia, mitochondria, and erythroblastic iron. Br J Haematol 1965;11:49-51.
15. Grasso JA, Hines JD. A comparative electron microscopic study of refractory and alcoholic sideroblastic anaemia. Br J Haematol 1969;17:35-44.
16. Porra RJ, Jones OTG. Studies on ferrochelatase. Biochem J 1963;87:181-192.
17. Barnes R, Jones OTG. The availability of iron for haem sythesis in red blood cells. Biochim Biophys Acta 1973;304:304-308.
18. Barnes R, Connelly JL, Jones OTG. The utilization of iron and its complexes by mammalian mitochondria. Biochem J 1972;128:1043-1055.
19. Romslo I, Flatmark T. Energy-dependent accumulation of iron by isolated rat liver mitochondria. I. General features. Biochim Biophys Acta 1973;305:29-40.
20. 2+. Biochim Biophys Acta 1973;325:38-46.
21. Romslo I, Flatmark T. Energy-dependent accumulation of iron by isolated rat liver mitochondria. III. Submitochondrial localization of the iron accumulated. Biochim Biophys Acta 1974;347:160-167.
22. Romslo I. Energy-dependent accumulation of iron by isolated rat liver mitochondria. IV. Relationship to the energy state of the mitochondria. Biochim Biophys Acta 1975;387:69-79.
23. Romslo I, Flatmark T. Energy-dependent accumulation of iron by isolated rat liver mitochondria. V. Effect on factors controlling respiration and oxidative phosphorylation. Biochim Biophys Acta 1975;387:80-94.
24. Romslo I. Energy-dependent accumulation of iron by isolated rabbit reticulocyte mitochondria. Biochim Biophys Acta 1974;357:34-72.
25. Flatmark T, Romslo I. Energy-dependent accumulation of iron by isolated rat liver mitochondria. Requirement for reducing equivalents and evidence for a unidirectional flux of Fe(II) across the inner membrane. J Biol Chem 1975;250:6433-6438.
26. Williams DM, Loukopoulos D, Lee GR, Cartwright GE. Role of copper in mitochondrial iron metabolism. Blood 1976;48:77-85.
27. Nilsen T, Romslo I. Transferrin as a donor of iron to mitochondria. Effect of pyrophosphate and relationship to mitochondrial metabolism and heme synthesis. Biochim Biophys Acta 1984;802:448-453.
28. Taketani S, Tanaka-Yoshioka A, Masaki R, Tashiro Y, Tokunaga R. Association of ferrochelatase with complex I in bovine heart mitochondria. Biochim Biophys Acta 1986;883:277-283.
29. Ponka P, Schulman HM, Cox TM. Iron metabolism in relation to heme synthesis. In: Dailey HA, ed. Biosynthesis of heme and chlorophylls. New York: McGraw-Hill, 1990;393-434.
30. Dailey HA. Conversion of coproporphyrinogen to protoheme in higher eukaryotes and bacteria: terminal three enzymes. In: Dailey HA, ed. Biosynthesis of heme and chlorophylls. New York: McGraw-Hill, 1990:123-161.
31. Freeman KJB, Haldar D. The inhibition of mammalian mitochondrial NADH oxidation by chloramphenicol and its isomers and analogues. Can J Biochem 1968;46:1003-1008.
32. Weaver J, Pollack S. Two types of receptors for iron on mitochondria. Biochem J 1990;271:463-466.
33. Pollack S. Receptor-mediated iron uptake and intracellular iron transport. Am J Hematol 1992;39:113-118.
34. Romslo I. Intracellular transport of iron. In: Jacobs A, Worwood M, eds. Iron in biochemistry and medicine. London: Academic Press, 1980:325-362.
35. Aoki Y. Multiple enzymatic detects in mitochondria in hematological cells of patients with primary sideroblastic anemia. J Clin Invest 1980;66:43-49.
36. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem 1992;61:1175-1212.
37. Nussbaum NJ. Concise review: genetic bases for sideroblastic anemia. Am J Hematol 1991;37:41-44.
38. Heim S, Mitelman F. Chromosome abnormalities in the myelodysplastic syndrome. Clin Haematol 1986;15:1003-1021.
39. Gattermann N, Aul C, Schneider W. Two types of acquired idiopathic sideroblastic anaemia (AISA). Br J Haematol 1990;74:45-52.
40. Knapp RH, Dewald GW, Pierre RV. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clin Proc 1985;60:507-516.
41. White AD, Culligan DJ, Hoy TG, Jacobs A. Extended cytogenetic follow-up of patients with myelodysplastic syndrome (MDS). Br J Haematol 1992;81:499-502.
42. Mecucci C, Van Orshoven A, Vermaelen K, Michaux JL, Tricot G, Louwagie A, Delannoy A, Van den Berghe H. 11q-chromosome is associated with abnormal iron stores in myelodysplastic syndromes. Cancer Genet Cytogenet 1987;27:39-44.
43. Heim S. Cytogenetic findings in primary and secondary MDS. Leuk Res 1992;16:43-46.
44. Geddes AA, Bowen DT, Jacobs A. Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndromes. Br J Haematol 1990;76:194-202.
45. Pedersen-Bjergaard J, Philip P, Larsen SO, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990;76:1083-1091.
46. Pui C-H, Behm FG, Raimondi SC, Dodge RK, George SL, Rivera GK, Mirro J, Kalwinsky DK, Dahl GV, Murphy SB, Crist WM, Williams DL. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 1989;321:136-142.
47. Berger R, Bernheim A, Weh HJ, Daniel MT, Flandrin G. Cytogenetic studies on acute monocytic leukemia. Leuk Res 1980;4:119-127.
48. Vermaelen K, Barbier D, Michaux JL, Tricot G, Casteeels, Van Daele M, Noens L, Van Hove W, Drochmans A, Louwagie A, Van den Berghe H. Anomalies of the long arm of chromosome 11 in human myelo- and lymphoproliferative disorders. I. Acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1983;10:105-116.
49. Johansson B, Mertens F, Heim S, Kristoffersson U, Mitelman F. Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL). Eur J Haematol 1991;47:17-27.
50. Dewald GW, Pierre RV, Phyliky RL. Three patients with structurally abnormal X chromosomes, each with Xq13 breakpoints and a history of idiopathic acquired sideroblastic anemia. Blood 1982;59:100-105.
51. Dewald GW, Brecher M. Travis LB, Stupca PJ. Twenty-six patients with hematological disorders and X chromosome abnormalities. Frequent idic(X)(q13) chromosomes and Xq13 anomalies associated with pathologic ringed sideroblasts. Cancer Genet Cytogenet 1989;42:173-185.
52. Shtalrid M. Chemke J, Rosensaft J, Chemla M, Berrebi A. Cytogenetical findings in refractory anemia with ring sideroblasts (RARS). Leuk Res 1991;15:(Suppl)22.
53. Heim S, Mitelman F. Chromosomal abnormalities in primary myelodysplastic syndromes. In: Mufti GJ, Gallon DAG, eds. The myelodysplastic syndromes. London: Churchill Livingstone, 1992:115-128.
54. Mufti GJ. Chromosomal deletions in the myelodysplastic syndrome. Leukemia Res 1992;16:35-41.
55. Rötig A, Colonna M, Bonnefont JP, Blanche S, Fischer A, Saudubray JM, Munnich A. Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet 1989;i:902-903.
56. Pearson HA, Lobel JS, Kocoshis SA, Naiman JL, Windmiller J, Lammi AT, Hoffman R, Marsh JC. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979;95:976-984.
57. Rötig A, Cormier V, Koll F, Mize CE, Saudubray J-M, Veerman A, Pearson HA, Munnich A. Site-specific deletions of the mitochondrial genome in the Pearson marrow-pancreas syndrome. Genomics 1991;10:502-504.
58. Mizoguchi H, Kubota K, Suda T, Takaku F, Miura Y. Erythroid and granulocyte/macrophage progenitor cells in primary acquired sideroblastic anemia. Int J Cell Cloning 1983;1:15-23.
59. Hutcheson JR, Ogawa M, Eguchi M, Spicer SS. Idiopathic sideroblastic anemia: presence of sideroblastic changes in the erythropietic precursors cultured from peripheral blood. Exp Hemat 1979;7:328-333.
60. Amenomori T, Tomonaga M, Jinnai I, Soda H, Nonaka H, Matsuo T, Yoshida Y, Kuriyama K, Ichimaru M, Suematsu T. Cytogenetic and cytochemical studies on progenitor cells of primary acquired sideroblastic anemia (PASA): involvement of multipotent myeloid stem cells in PASA clone and mosaicism with normal clone. Blood 1987;70:1367-1372.
61. Aul C, Gattermann N, Schneider W. Age related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 1992;82:358-367.
62. Joenje H (ed). Molecular basis of aging: mitochondrial degeneration and oxidative damage. Mutation Res 1992;275:(spec issue),(3-6).
63. Kadenbach B, Müller-Höcker J. Mutations of mitochondrial DNA and human death. Naturwissenschaften 1990;77:221-225.
64. Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989;i:642-645.
65. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992;256:628-632.
66. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutation Res 1992;275:169-180.
67. Cortopassi GA, Arnheim N. Detection of a specific mitochondria! DNA deletion in tissues of older individuals. Nucleic Acids Res 1990;18:6927-6933.
68. Cortopassi GA, Pasinetti G, Arnheim N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging tissues. Proc Nat Acad Sci USA 1992;89:7370-7374.
69. Hattori K, Tanaka M, Sugiyama S, Obayashi T, Ito T, Satake T, Hanaki Y, Asai Y, Nagano M, Ozawa T. Age dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am Heart J 1991;121:1735-1742.
70. Hayakawa M, Torii K, Sugiyama S, Tanaka M, Ozawa T. Age-associated accumulation of 8-hydroxy-deoxyguanosine in mitochondrial DNA of human diaphragm. Biochem Biophys Res Commun 1991;179:1023-1029.
71. Ikebe S, Tanaka M, Ohno K, Sato W, Hattori K, Kondo T, Mizuno Y, Ozawa T. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 1990;170:1044-1048.
72. Katayama M, Tanaka M, Yamamoto H, Obayashi T, Nimura Y, Ozawa T. Deleted mitochondrial DNA in the skeletal muscle of aged individuals. Biochem Int 1991;25:47-56.
73. Linnane AW, Baumer A, Maxwell RJ, Preston H, Zhang C, Marzuki S. Mitochondrial gene mutation: the ageing process and degenerative disease. Biochemistry 1990;22:1067-1076.
74. Sugiyama S, Hattori K, Hayakawa M, Ozawa T. Quantitative analysis of age associated accumulation of mitochondrial DNA with deletion in human hearts. Biochem Biophys Res Commun 1991;180:894-899.
75. Yen TC, Su JH, King KL, Wei YH. Ageing associated 5 kb deletion in human liver mitochondrial DNA. Biochem Biophys Res Commun 1991;178:124-131.
76. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-719.
77. Wickramasinghe SN, Chalmers DG, Cooper EH. A study of ineffective erythropoiesis in sideroblastic anaemia and erythraemic myelosis. Cell Tissue Kinet 1968;1:43-50.
78. Wickramasinghe SN, Hughes M. Capacity of ringed sideroblasts to synthesize nucleic acids and protein in patients with primary acquired sideroblastic anaemia. Br J Haematol 1978;38:345-352.
79. Hast R. Sideroblasts in myelodysplasia: their nature and clinical significance. Scand J Haematol 1986;36(suppl 45),53-55.
80. Lutton JD, Levere RD, Abraham NG. Physiologic role of heme and cytochrome P-450 in hematopoietic cells. Proc Soc Exp Biol Med 1991;196:260-269.
81. Gattermann N, Lotz H, Aul C, Schneider W. No large deletions of mitochondrial DNA in acquired idiopathic sideroblastic anemia (AISA). Am J Hematol 1992;41:297.
82. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalopathies. Nature 1990;348:651-653.
83. Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-433.
84. Moraes CT, Ciacci F, Bonilla E, Ionasescu V, Schon EA, DiMauro S. A mitochondrial tRNA anticodon swap associated with a muscle disease. Nature Genet 1993;4:284-288.
85. Shoffner JM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERFF) is associated with a mitochondrial DNA tRNALys mutation. Cell 1990;61:931-937.
86. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AMS, Elsas LJ, Nikoskelainen EK. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-1430.
87. Leu(UUR). Lancet 1991;338:143-147.